COLL News and Press, Collegium Pharmaceutical Inc. From 12/06/21

STOUGHTON, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has been named one of the Top Places to Work in Massachusetts in ...

Pharma/biotechnology is the most attractive healthcare subsector. Life science tools have performed the best in one year, but are overvalued now. Focus on IDNA. A list of cheap stocks. For further details see: IDNA: Healthcare Dashboard For November

Collegium Pharmaceutical (NASDAQ:COLL) has surged pre-market after announcing an accelerated share repurchase agreement with Jefferies to buyback $25M of its common stock. The agreement is being executed under the pharmaceutical firm's $100M share repurchase program authorized in August 2021....

STOUGHTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has entered into an Accelerated Share Repurchase ("ASR") agreement ...

STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences: ...

STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences: ...

Collegium Pharmaceutical, Inc. (COLL) Q3 2021 Earnings Conference Call November 4, 2021, 04:30 PM ET Company Participants Julie Fallon - Senior Vice President, Investor Relations, MacDougall Advisors Joe Ciaffoni - President, CEO & Director Colleen Tupper - EVP & CFO Scott Dreyer - EV...

Image source: The Motley Fool. Collegium Pharmaceutical, inc (NASDAQ: COLL) Q3 2021 Earnings Call Nov 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Collegium Pharmaceutical, inc (COLL) Q3 2021 Earnings Call Tra...

Collegium Pharmaceutical (NASDAQ:COLL): Q3 GAAP EPS of $0.22 misses by $0.14. Revenue of $78.84M (-0.4% Y/Y) misses by $5.81M. Press Release For further details see: Collegium Pharmaceutical EPS misses by $0.14, misses on revenue

- Board of Directors Has Authorized $25 Million Accelerated Share Repurchase Program - - Net Income of $8.0 Million and Adjusted EBITDA of $37.3 Million - - Full-Year 2021 Guidance Updated - - Conference Call Scheduled for Today at 4:30 p.m. ET - STOUGHTON, Mass., ...